| Literature DB >> 26943964 |
María F Coronel1, María C Raggio1, Natalia S Adler1, Alejandro F De Nicola2, Florencia Labombarda2, Susana L González3.
Abstract
Neuropathic pain is a frequent complication of spinal cord injury (SCI), still refractory to conventional treatment. Glial cell activation and cytokine production contribute to the pathology of central neuropathic syndromes. In this study we evaluated the effects of progesterone, a neuroactive steroid, on pain development and the spinal expression of IL-1β, its receptors (IL-1RI and IL-1RII) and antagonist (IL-1ra), IL-6 and TNFα, and NR1 subunit of NMDAR. Our results show that progesterone, by modulating the expression of pro-inflammatory cytokines and neuronal IL-1RI/NR1 colocalization, emerges as a promising agent to prevent chronic pain after SCI.Entities:
Keywords: Chronic pain; Glial activation; NMDA receptor; Neuroactive steroids; Pro-inflammatory cytokines; Spinal cord
Mesh:
Substances:
Year: 2016 PMID: 26943964 DOI: 10.1016/j.jneuroim.2016.01.011
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478